DSpace@İnönü

Yazar "Caglayan, M" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Yazar "Caglayan, M" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Sırala: Sıra: Sonuçlar:

  • Outcome of COVID-19 in patients with chronic myeloid leukemia receiving 
    Basci, S; Ata, N; Altuntas, F; Yigenoglu, TN; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Erkurt, MA; Turgut, B; Caglayan, M; Ayvali, MO; Celik, O; Ulgu, MM; Birinci, S (2020)
    Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with ...
  • Clinical outcomes of non-diabetic COVID-19 patients with different blood 
    Haymana, C; Demirci, I; Tasci, I; Cakal, E; Salman, S; Ertugrul, D; Ata, N; Unluturk, U; Dagdelen, S; Atmaca, A; Sahin, M; Celik, O; Demir, T; Emral, R; Sahin, I; Caglayan, M; Satman, I; Sonmez, A (2021)
    Purpose New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with diabetes. However, there are insufficient data about the effect of hyperglycemia on COVID-19 prognosis in non-diabetic patients. This ...
  • Convalescent plasma therapy in patients with COVID-19 
    Altuntas, F; Ata, N; Yigenoglu, TN; Basci, S; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Kinik, K; Haznedaroglu, I; Yilmaz, FM; Kilic, I; Demircioglu, S; Yosunkaya, A; Erkurt, MA; Turgut, B; Caglayan, M; Celik, O (2021)
    Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
  • Clinical characteristics and outcomes of COVID-19 in patients with type 
    Sonmez, A; Demirci, I; Haymana, C; Tasci, I; Dagdelen, S; Salman, S; Ata, N; Sahin, I; Emral, R; Cakal, E; Atmaca, A; Sahin, M; Celik, O; Demir, T; Ertugrul, D; Unluturk, U; Caglayan, M; Satman, I (2021)
    Background Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe course in patients with type 2 diabetes mellitus (T2DM). However, severe adverse outcomes are not recorded in all patients. ...
  • Convalescent plasma therapy in patients with COVID-19 
    Altuntas, F; Ata, N; Yigenoglu, TN; Basci, S; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Kinik, K; Haznedaroglu, I; Yilmaz, FM; Kilic, I; Demircioglu, S; Yosunkaya, A; Erkurt, MA; Turgut, B; Caglayan, M; Celik, O (2021)
    Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
  • Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus 
    Emral, R; Haymana, C; Demirci, I; Tasci, I; Sahin, M; Cakal, E; Ata, N; Unluturk, U; Demir, T; Ertugrul, D; Sahi, I; Atmaca, A; Celik, O; Caglayan, M; Arga, KY; Dagdelen, S; Salman, S; Satman, I; Sonmez, A (2021)
    Introduction To investigate the effect of preexisting treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) on COVID-19-related hospitalization and mortality in patients with type 2 diabetes mellitus (T2DM). Methods ...
  • Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus 
    Emral, R; Haymana, C; Demirci, I; Tasci, I; Sahin, M; Cakal, E; Ata, N; Unluturk, U; Demir, T; Ertugrul, D; Sahin, I; Atmaca, A; Celik, O; Caglayan, M; Arga, KY; Dagdelen, S; Salman, S; Satman, I; Sonmez, A (2021)
  • Unexpectedly lower mortality rates in COVID-19 patients with and without 
    Satman, I; Demirci, I; Haymana, C; Tasci, I; Salman, S; Ata, N; Dagdelen, S; Sahin, I; Emral, R; Cakal, E; Atmaca, A; Sahin, M; Celik, O; Demir, T; Ertugrul, D; Unluturk, U; Arga, KY; Caglayan, M; Sonmez, A (2021)
    Aims: Type 2 diabetes mellitus (T2DM) is a risk factor for severe COVID-19. Our aim was to compare the clinical outcomes of patients with and without T2DM during the first hit of COVID-19 in Istanbul.& nbsp; Methods: A ...
  • The clinical outcomes of COVID-19 infection in patients with a history 
    Sahin, M; Haymana, C; Demirci, I; Tasci, I; Rifat, E; Unluturk, U; Satman, I; Demir, T; Cakal, E; Ata, N; Ertugrul, D; Salman, S; Sahin, I; Dagdelen, S; Celik, O; Caglayan, M; Atmaca, A; Sonmez, A (2021)
    Background There are scarce published data in differentiated thyroid cancer patients about new coronavirus disease 2019 (COVID-19) disease outcomes and mortality. Here, we evaluated COVID-19 infection outcomes and mortality ...
  • COVID-19 clinical course and blood groups: Turkish population-based 
    Dal, MS; Ata, N; Altuntas, F; Basci, S; Yigenoglu, TN; Korkmaz, S; Namdaroglu, S; Basturk, A; HacibekIroglu, T; Dogu, MH; Berber, I; Dal, K; Erkurt, MA; Turgut, B; Caglayan, M; Imrat, E; Celik, O; Ulgu, MM; Birinci, S (2021)
    Background/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 ...
  • Convalescent plasma therapy in patients with COVID-19 
    Altuntas, F; Ata, N; Yigenoglu, TN; Basci, S; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Kinik, K; Haznedaroglu, I; Yilmaz, FM; Kilic, I; Demircioglu, S; Yosunkaya, A; Erkurt, MA; Turgut, B; Caglayan, M; Celik, O (2021)
    Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
  • Convalescent plasma therapy in patients with COVID-19 
    Altuntas, F; Ata, N; Yigenoglu, TN; Basci, S; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Kinik, K; Haznedaroglu, I; Yilmaz, FM; Kilic, I; Demircioglu, S; Yosunkaya, A; Erkurt, MA; Turgut, B; Caglayan, M; Celik, O (2021)
    Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
  • Convalescent plasma therapy in patients with COVID-19 
    Altuntas, F; Ata, N; Yigenoglu, TN; Basci, S; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Kinik, K; Haznedaroglu, I; Yilmaz, FM; Kilic, I; Demircioglu, S; Yosunkaya, A; Erkurt, MA; Turgut, B; Caglayan, M; Celik, O (2021)
    Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
  • Clinical Characteristics and Outcomes of COVID-19 Patients with 
    Sahin, I; Haymana, C; Demir, T; Demirci, I; Tasci, I; Atmaca, A; Cakal, E; Ata, N; Emral, R; Unluturk, U; Ertugrul, D; Salman, S; Sahin, M; Dagdelen, S; Celik, O; Caglayan, M; Satman, I; Sonmez, A (2022)
    Purpose While obesity is related to more severe outcomes of coronavirus disease 2019 (COVID-19), factors leading to poor prognosis still remain unclear. The present study evaluated the outcomes of COVID-19 patients who ...
  • No association of anti-osteoporosis drugs with COVID-19-related outcomes 
    Atmaca, A; Demirci, I; Haymana, C; Tasci, I; Sahin, I; Cakal, E; Ata, N; Dagdelen, S; Salman, S; Emral, R; Sahin, M; Celik, O; Demir, T; Ertugrul, D; Unluturk, U; Caglayan, M; Satman, I; Sonmez, A (2022)
    This study was performed to evaluate whether the use of drugs in the treatment of osteoporosis in women is associated with COVID-19 outcomes. The results showed that the risk of hospitalization, intensive care unit admission, ...
  • Higher rate of COVID-19 mortality in patients with type 1 than type 2 
    Demirci, I; Haymana, C; Tasci, I; Satman, I; Atmaca, A; Sahin, M; Ata, N; Unluturk, U; Cakal, E; Dagdelen, S; Sahin, I; Celik, O; Ertugrul, D; Demir, T; Emral, R; Caglayan, M; Salman, S; Birinci, S; Sonmez, A (2022)
    Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 diabetes (T2DM) are lacking. The purpose of this ...
  • No association of Gaucher disease with COVID-19-related outcomes: a 
    Demirci, I; Demir, T; Dagdelen, S; Haymana, C; Tasci, I; Atmaca, A; Ertugrul, D; Ata, N; Sahin, M; Salman, S; Sahin, I; Emral, R; Unluturk, U; Cakal, E; Celik, O; Caglayan, M; Satman, I; Sonmez, A (2022)
    Background It is well documented that patients with chronic metabolic diseases, such as diabetes and obesity, are adversely affected by the COVID-19 pandemic. However, when the subject is rare metabolic diseases, there are ...